AbbVie (NYSE: ABBV) announced today that Health Canada has approved MAVIRET (glecaprevir/pibrentasvir tablets) for the treatment of acute and chronic hepatitis C virus (HCV) infection in adults and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback